🇺🇸 FDA
Pipeline program

AG-881

AG881-C-005

Phase 1 small_molecule completed

Quick answer

AG-881 for Healthy Male Participants is a Phase 1 program (small_molecule) at Agios Netherlands B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Agios Netherlands B.V.
Indication
Healthy Male Participants
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials